282 related articles for article (PubMed ID: 21157381)
1. Block of purinergic P2X7R inhibits tumor growth in a C6 glioma brain tumor animal model.
Ryu JK; Jantaratnotai N; Serrano-Perez MC; McGeer PL; McLarnon JG
J Neuropathol Exp Neurol; 2011 Jan; 70(1):13-22. PubMed ID: 21157381
[TBL] [Abstract][Full Text] [Related]
2. P2X7R suppression promotes glioma growth through epidermal growth factor receptor signal pathway.
Fang J; Chen X; Zhang L; Chen J; Liang Y; Li X; Xiang J; Wang L; Guo G; Zhang B; Zhang W
Int J Biochem Cell Biol; 2013 Jun; 45(6):1109-20. PubMed ID: 23523696
[TBL] [Abstract][Full Text] [Related]
3. Roles of purinergic P2X
McLarnon JG
Cancer Lett; 2017 Aug; 402():93-99. PubMed ID: 28536012
[TBL] [Abstract][Full Text] [Related]
4. P2X7 receptor antagonism inhibits tumour growth in human high-grade gliomas.
Kan LK; Seneviratne S; Drummond KJ; Williams DA; O'Brien TJ; Monif M
Purinergic Signal; 2020 Sep; 16(3):327-336. PubMed ID: 32583309
[TBL] [Abstract][Full Text] [Related]
5. The P2X7 receptor antagonist Brilliant Blue G attenuates contralateral rotations in a rat model of Parkinsonism through a combined control of synaptotoxicity, neurotoxicity and gliosis.
Carmo MR; Menezes AP; Nunes AC; Pliássova A; Rolo AP; Palmeira CM; Cunha RA; Canas PM; Andrade GM
Neuropharmacology; 2014 Jun; 81():142-52. PubMed ID: 24508709
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of the P2X(7) receptor in rat C6 glioma cells.
Wei W; Ryu JK; Choi HB; McLarnon JG
Cancer Lett; 2008 Feb; 260(1-2):79-87. PubMed ID: 18039556
[TBL] [Abstract][Full Text] [Related]
7. Microglial P2X₇ receptor in the hypothalamic paraventricular nuclei contributes to sympathoexcitatory responses in acute myocardial infarction rat.
Du D; Jiang M; Liu M; Wang J; Xia C; Guan R; Shen L; Ji Y; Zhu D
Neurosci Lett; 2015 Feb; 587():22-8. PubMed ID: 25524407
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting purinergic P2X7 receptors with the antagonist brilliant blue G is neuroprotective in an intranigral lipopolysaccharide animal model of Parkinson's disease.
Wang XH; Xie X; Luo XG; Shang H; He ZY
Mol Med Rep; 2017 Feb; 15(2):768-776. PubMed ID: 28035410
[TBL] [Abstract][Full Text] [Related]
9. Expression of macrophage inflammatory protein-1α and monocyte chemoattractant protein-1 in glioma-infiltrating microglia: involvement of ATP and P2X₇ receptor.
Fang KM; Wang YL; Huang MC; Sun SH; Cheng H; Tzeng SF
J Neurosci Res; 2011 Feb; 89(2):199-211. PubMed ID: 21162127
[TBL] [Abstract][Full Text] [Related]
10. A P2X7 receptor antagonist reverses behavioural alterations, microglial activation and neuroendocrine dysregulation in an unpredictable chronic mild stress (UCMS) model of depression in mice.
Farooq RK; Tanti A; Ainouche S; Roger S; Belzung C; Camus V
Psychoneuroendocrinology; 2018 Nov; 97():120-130. PubMed ID: 30015007
[TBL] [Abstract][Full Text] [Related]
11. The P2X7 receptor links mechanical strain to cytokine IL-6 up-regulation and release in neurons and astrocytes.
Lu W; Albalawi F; Beckel JM; Lim JC; Laties AM; Mitchell CH
J Neurochem; 2017 May; 141(3):436-448. PubMed ID: 28244110
[TBL] [Abstract][Full Text] [Related]
12. Involvement of microglial P2X7 receptors and downstream signaling pathways in long-term potentiation of spinal nociceptive responses.
Chu YX; Zhang Y; Zhang YQ; Zhao ZQ
Brain Behav Immun; 2010 Oct; 24(7):1176-89. PubMed ID: 20554014
[TBL] [Abstract][Full Text] [Related]
13. Oxaliplatin evokes P2X7-dependent glutamate release in the cerebral cortex: A pain mechanism mediated by Pannexin 1.
Di Cesare Mannelli L; Marcoli M; Micheli L; Zanardelli M; Maura G; Ghelardini C; Cervetto C
Neuropharmacology; 2015 Oct; 97():133-41. PubMed ID: 26071109
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of P2X7 Receptor Ameliorates Nuclear Factor-Kappa B Mediated Neuroinflammation Induced by Status Epilepticus in Rat Hippocampus.
Huang C; Chi XS; Li R; Hu X; Xu HX; Li JM; Zhou D
J Mol Neurosci; 2017 Oct; 63(2):173-184. PubMed ID: 28856625
[TBL] [Abstract][Full Text] [Related]
15. Tissue distribution and antitumor activity of topotecan delivered by intracerebral clysis in a rat glioma model.
Kaiser MG; Parsa AT; Fine RL; Hall JS; Chakrabarti I; Bruce JN
Neurosurgery; 2000 Dec; 47(6):1391-8; discussion 1398-9. PubMed ID: 11126910
[TBL] [Abstract][Full Text] [Related]
16. Early P2X7R-dependent activation of microglia during the asymptomatic phase of autoimmune encephalomyelitis.
Grygorowicz T; Strużyńska L
Inflammopharmacology; 2019 Feb; 27(1):129-137. PubMed ID: 30209761
[TBL] [Abstract][Full Text] [Related]
17. Activation of P2X7R and downstream effects in bleomycin treated lung epithelial cells.
Bläsche R; Ebeling G; Perike S; Weinhold K; Kasper M; Barth K
Int J Biochem Cell Biol; 2012 Mar; 44(3):514-24. PubMed ID: 22192844
[TBL] [Abstract][Full Text] [Related]
18. The impact of P2X7 receptor antagonist, brilliant blue G on graft-versus-host disease in mice after allogeneic hematopoietic stem cell transplantation.
Zhong X; Zhu F; Qiao J; Zhao K; Zhu S; Zeng L; Chen X; Xu K
Cell Immunol; 2016 Dec; 310():71-77. PubMed ID: 27544305
[TBL] [Abstract][Full Text] [Related]
19. P2X7 Receptor Suppression Preserves Blood-Brain Barrier through Inhibiting RhoA Activation after Experimental Intracerebral Hemorrhage in Rats.
Zhao H; Zhang X; Dai Z; Feng Y; Li Q; Zhang JH; Liu X; Chen Y; Feng H
Sci Rep; 2016 Mar; 6():23286. PubMed ID: 26980524
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) disrupts blood-brain barrier integrity through a mechanism involving P2X7 receptors.
Rubio-Araiz A; Perez-Hernandez M; Urrutia A; Porcu F; Borcel E; Gutierrez-Lopez MD; O'Shea E; Colado MI
Int J Neuropsychopharmacol; 2014 Aug; 17(8):1243-55. PubMed ID: 24626059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
